NCT07527832 An Observational Study to Learn About the Medicine - BEVACIZUMAB BS [Pfizer] in Colorectal Cancer Patients From Japan. Status RECRUITING Phase N/A
NCT05745857 Oral Bevacizumab-800CW and Cetuximab-800CW Administration to Detect Early Esophageal Adenocarcinomas Status RECRUITING Phase PHASE2
NCT05571267 Safety Study of Zimura in Combination With Anti-VEGF Therapy in Patients With Neovascular AMD Status TERMINATED Phase PHASE2
NCT05446870 Pembrolizumab With Chemotherapy and MK-4830 for Treating Participants With Ovarian Cancer (MK-4830-002) Status COMPLETED Phase PHASE2
NCT05318443 A Study Exploring Efficacy of SIBP04 in Subjects With Non-squamous Non-small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT05110118 Pharmacokinetic Characteristics, Safety, Tolerability and Immunogenicity of LY01008 and Avastin in Healthy Chinese Male Subjects Status COMPLETED Phase PHASE1
NCT03676192 To Compare Efficacy and Safety of CT-P16 and European Union-Approved Avastin as First-Line Treatment for Metastatic or Recurrent Non-Squamous Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT03659305 Pharmacokinetic Equivalence and Safety Study of RPH-001 and Avastin® Status COMPLETED Phase PHASE1
NCT03390673 To Demonstrate Equivalent Pharmacokinetic Properties of HD204 and Bevacizumab (Avastin®) in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT02776683 Open-label, Single Arm Trial of BI 695502 in Patients With Previously Untreated Metastatic Colorectal Cancer Status COMPLETED Phase PHASE3
NCT02348918 Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema Status COMPLETED Phase PHASE2
NCT02272413 Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin® Plus Chemotherapy in Patients With Lung Cancer Status COMPLETED Phase PHASE3
NCT02031991 A Pharmacokinetic Study Comparing PF-06439535 And Bevacizumab In Healthy Male Volunteers (REFLECTIONS B739-01) Status COMPLETED Phase PHASE1
NCT01972490 Avastin in Combination With Chemotherapy for RAS Mutant Unresectable Colorectal Liver-limited Metastases Status COMPLETED Phase PHASE4
NCT01921790 Avastin+ GemAOD As First-Line Treatment in NK/T Cell Lymphoma Status UNKNOWN Phase PHASE2
NCT01526837 Bevacizumab (Avastin) Into the Tumor Resection Cavity in Subjects With Glioblastoma Multiforme at First Recurrence Status TERMINATED Phase PHASE1
NCT01507740 Profile of Soluble and Cellular Biomarkers and of Functional Imaging During Antiangiogenic Therapies in Cancer Patients Status TERMINATED Phase N/A
NCT01473251 Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration Status COMPLETED Phase NA
NCT01231633 Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema Caused by Central Retinal Vein Occlusion (CRVO) Status COMPLETED Phase NA
NCT01186406 Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM) Status TERMINATED Phase PHASE2